CoChat

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis.

Chu, Cindy S., Bancone, Germana, Soe, Nay Lin, Carrara, Verena I., Gornsawun, Gornpan, Nosten, François · 2019 · Wellcome Open Research
Cited by 10

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Radical cure of Plasmodium vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals employs weekly primaquine dosing. This is the only recommended regimen for this patient sub-group. If national malaria programs mandate daily primaquine dosing (the recommended regimen for G6PD normal individuals), then G6PD testing before prescription is necessary to avoid iatrogenic haemolysis in G6PD deficient individuals. In this case series, two P. vivax infected patients with unknown G6PD status from two different countries were prescribed primaquine as per national malaria program guidelines. During treatment both patients presented to the clinic with symptoms of anaemia after taking primaquine incorrectly. The clinical management of the iatrogenic severe haemolysis that occurred in these patients demonstrates the various adverse effects primaquine can cause, that other common medical treatments also have haemolytic potential, and how the diagnosis of G6PD deficiency can be elusive during acute haemolysis. Health care providers should provide careful instructions about primaquine dosing, be watchful for haemolysis, and have a high index of suspicion for G6PD deficiency in the presence of haemolysis if the G6PD status is previously unknown.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12688/wellcomeopenres.15100.1

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 19

  1. A Alving, 1960, Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration: a preliminary report., Bull World Health Organ., 22, 621-31
  2. T Leslie, 2008, A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan., PLoS One., 3, e2861, 10.1371/journal.pone.0002861 · DOI
  3. S Kheng, 2015, Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency., BMC Med., 13, 203, 10.1186/s12916-015-0441-1 · DOI
  4. K Burgoine, 2010, The reality of using primaquine., Malar J., 9, 376, 10.1186/1475-2875-9-376 · DOI · Paper page
  5. R Howes, 2012, G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map., PLoS Med., 9, e1001339, 10.1371/journal.pmed.1001339 · DOI · Paper page
  6. I Nuchprayoon, 2002, Glucose-6-phosphate dehydrogenase (G6PD) mutations in Thailand: G6PD Viangchan (871G>A) is the most common deficiency variant in the Thai population., Hum Mutat., 19, 185, 10.1002/humu.9010 · DOI
  7. V Laosombat, 2005, Molecular heterogeneity of glucose-6-phosphate dehydrogenase (G6PD) variants in the south of Thailand and identification of a novel variant (G6PD Songklanagarind)., Blood Cells Mol Dis., 34, 191-6, 10.1016/j.bcmd.2004.11.001 · DOI
  8. H Matsuoka, 2004, Glucose-6-phosphate dehydrogenase (G6PD) mutations in Myanmar: G6PD Mahidol (487G>A) is the most common variant in the Myanmar population., J Hum Genet., 49, 544-7, 10.1007/s10038-004-0187-7 · DOI
  9. G Bancone, 2016, Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects., PLoS One., 11, e0151898, 10.1371/journal.pone.0151898 · DOI
  10. J Mehta, 1990, Ascorbic-acid-induced haemolysis in G-6-PD deficiency., Lancet., 336, 944, 10.1016/0140-6736(90)92317-B · DOI · Paper page
  11. A Tarlov, 1962, Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance., Arch Intern Med., 109, 209-34, 10.1001/archinte.1962.03620140081013 · DOI · Paper page
  12. W Ramos Júnior, 2010, Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon., Braz J Infect Dis., 14, 410-2, 10.1016/S1413-8670(10)70084-2 · DOI
  13. G Brewer, 1962, The hemolytic effect of primaquine. XV. Role of methemoglobin., J Lab Clin Med., 59, 905-17
  14. S Wu, 2018, Hemolytic jaundice induced by pharmacological dose ascorbic acid in glucose-6-phosphate dehydrogenase deficiency: A case report., Medicine (Baltimore)., 97, e13588, 10.1097/MD.0000000000013588 · DOI
  15. P Pootrakul, 2000, A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in Thai patients with thalassemia., Blood., 96, 2606-12, 10.1182/blood.V96.7.2606 · DOI · Paper page
  16. R Dern, 1954, The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character., J Lab Clin Med., 44, 171-6
  17. C Chu, 2017, Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens., PLoS Med., 14, e1002224, 10.1371/journal.pmed.1002224 · DOI · Paper page
  18. S Pal, 2019, Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient., Am J Trop Med Hyg., 100, 213-221, 10.4269/ajtmh.18-0612 · DOI · Paper page
  19. T Weppelmann, 2017, Field Trial of the CareStart Biosensor Analyzer for the Determination of Glucose-6-Phosphate Dehydrogenase Activity in Haiti., Am J Trop Med Hyg., 97, 1262-70, 10.4269/ajtmh.16-0714 · DOI · Paper page

Cited by

See all 10

Metadata

Authors
Chu, C. S., Bancone, G., Soe, N. L., Carrara, V. I., Gornsawun, G., & Nosten, F.
Venue
Wellcome Open Research
Published
2019-02-06
Volume
4
Pages
25
ISSN
2398-502X
Cited by
10
References
3
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
Wellcome Trust (089179)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis. https://app.cochat.ai/papers/10.12688/wellcomeopenres.15100.1
The paper
Chu, C. S., Bancone, G., Soe, N. L., Carrara, V. I., Gornsawun, G., & Nosten, F. (2019). The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis. Wellcome Open Research. https://doi.org/10.12688/wellcomeopenres.15100.1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.